From a study of 1,066 individuals who recovered from COVID-19 in Japan,
"The participants completed self-report questionnaires at 3, 6, and 12 months after diagnosis..
Long COVID symptoms and psychological status were assessed using the Hospital Anxiety and Depression Scale (HADS) and Fear of COVID-19 Scale (FCV-19S)..
Three months after diagnosis, 20.1% of the participants exhibited high anxiety (HADS-Anxiety [A] score ≥ 8), 23.6% had high depression (HADS-Depression [D] score ≥ 8), and 35.3% reported high levels of COVID-19-related fear (FCV-19S score ≥ 21).
[It was demonstrated that] the individuals with high HADS-A and HADS-D scores consistently experienced multiple post-COVID symptoms over time [up to 12 months]..
The participants with high HADS-A and HADS-D scores shared similar characteristics, including younger age, female sex, and mild severity of illness..
The elevated HADS scores in individuals with mild COVID-19 suggest that even those with less severe illness may experience significant mental health challenges."
We are challenging something serious without seriously thinking.
'Anxiety, depression, and fear after coronavirus disease 2019 infection and their association with long coronavirus disease symptoms' frontiersin.org/journals/psych…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
@PaulRoundy1 No, Paul. I see that the neurologic complications in children is becoming more prevalent since last year (i.e., after the appearance of the Omicron strain).
@PaulRoundy1 FYI, in Japan, among the officially reported COVID deaths of children from Jan. to Sep., 2022, the major endogenous cause was central nervous system symptoms (19/50; 38%), which is much higher than circulatory (18%) & respiratory (8%) ones.
@PaulRoundy1 I should note that, as a feature of deaths due to the central nervous system abnormalities, the durations from onset to death of those children were quite short: 3.0 days in median with 0-2 days: 46%, 3-6 days: 29% & 7 days or more: 25%).
Let me note below the failures that we experienced in international cooperation for controlling the COVID-19 pandemic: 1) the lack of timely notification of the initial outbreak of COVID-19;
...
(1/6)
2) costly delays in acknowledging the crucial airborne exposure pathway of the virus, and in implementing measures; 3) the lack of coordination among countries regarding suppression strategies;
(2/6)
4) the failure of governments to examine evidence and adopt best practices for controlling the pandemic; 5) the shortfall of global funding for low-income and middle-income countries (LMICs);
(3/6)
1/11
The National Institute of Infectious Diseases (NIID), the authority on infectious disease issues in Japan, published a report on 30 June 2022 entitled "Acute hepatitis of unknown etiology in children in Japan (1st report)".
2/11
The report revealed details of pathogen testings regarding the children's acute hepatitis for different age groups based on of a survey performed by the Ministry of Health, Labor and Welfare of Japan (& NIID) for the period from 1 October 2021 to 23 June 2022.
3/11
Among 62 children (male: 34, female: 28, median age: 5 yo) with the acute hepatitis of unknown etiology,
- 57 of 61 cases (93%) were detected in the week of 14 February 2022 or later.
- 12 of 55 cases (22%) were at least once vaccinated;
2/3 The 62 cases met the following criteria:
-Period: From October 1, 2021 to June 23, 2022;
-Patient: Hospitalized children of 16 y/o or younger;
-Symptoms: Acute hepatitis with AST or ALT exceeding 500 IU/L without involvement of hepatitis A to E viruses.
3/3 Among the 62 cases,
- adenovirus positive: 5 cases (type 1 & 2: 2 cases and type unknown: 3 cases);
- SARS-CoV-2 positive:5 cases;
- these PCR tests were performed when their symptoms were recognized;
- liver transplant: 0;
- 7 cases are still under complete checkup.